R. Ribeiro

High Doses of Inhaled Nitric Oxide as an Innovative Antimicrobial Strategy for Lung Infections

M. Cypel, L. Sorbo, V. Michaelsen, 2022, Biomedicines.

Successful 3-day lung preservation using a cyclic normothermic ex vivo lung perfusion strategy

L. Brochard, S. Keshavjee, T. Waddell, 2022, EBioMedicine.

Safety of continuous 12-hour delivery of antimicrobial doses of inhaled nitric oxide during ex vivo lung perfusion.

S. Keshavjee, M. Cypel, V. Michaelsen, 2020, The Journal of thoracic and cardiovascular surgery.

TRANSLATIONAL RESEARCH 1 DEVELOPING UNIVERSAL BLOOD TYPE DONOR ORGANS USING EX VIVO ABO ENZYMATIC TREATMENT

S. Withers, S. Keshavjee, T. Waddell, 2020 .

A novel pre-clinical strategy to deliver antimicrobial doses of inhaled nitric oxide

S. Keshavjee, L. Del Sorbo, M. Cypel, 2021, PloS one.

Static lung storage at 10°C maintains mitochondrial health and preserves donor organ function

L. Brochard, S. Keshavjee, E. Abdelnour-Berchtold, 2021, Science Translational Medicine.

Ex vivo enzymatic treatment converts blood type A donor lungs into universal blood type lungs

S. Withers, S. Keshavjee, T. Waddell, 2022, Science Translational Medicine.

Developing Universal ABO Blood Type Donor Lungs with Ex Vivo Enzymatic Treatment: A Proof of Concept Feasibility Study

S. Withers, S. Keshavjee, T. Waddell, 2021 .

Incidence of post-transplant cytomegalovirus viremia in patients receiving lungs after ex vivo lung perfusion

Deepali Kumar, A. Humar, S. Keshavjee, 2022, JTCVS Open.